White Coat Productions documentary in development explores the global impact of vaccine delivery advancements
The quest to improve vaccination efforts in developing nations may yield
huge side benefits to the industrialized world; an end to needle
injections.
Catalent scientists have developed a quick dissolving tablet they hope
can provide an option to replace some needle injections for vaccination.
Imagine back-to-school doctor visits without your children kicking and
screaming, afraid of their doctor’s syringe!
There are clear additional benefits in the efforts to vaccinate
impoverished populations in remote corners of the world. Currently, many
vaccines require a “cold-chain” so their temperature is maintained
constantly by refrigeration throughout delivery. The need for a cold
chain is a serious obstacle in trying to reach regions where
refrigeration isn’t available, and where temperatures are often higher.
Recently published in the journal Vaccine, Johns Hopkins Bloomberg
School of Health Professor Bruce Lee, M.D. reports of a significant
economic advantage in developing temperature stable vaccines.
As part of an effort to eliminate the cold chain, scientists using
temperature stable Zydis® technology are customizing their formulations
and say they are on the cutting edge of manufacturing vaccine doses that
dissolve on the tongue within a few seconds, eliminating the need for
needle injections, which can also pose challenges for maintaining
sterility in some environments.
Research and development is currently being conducted at Catalent’s
laboratories in Swindon, U.K., where chemists have already been
successful in developing commercial platforms for treatments such as
immunotherapy for allergy relief.
A documentary on the need for improved vaccination deployment is in
development at White Coat Productions, a video content creation firm
based in the DC/Baltimore metro area.
Video news release available at the following link:
https://vimeo.com/227783144
SME’s
available on appointment basis
Zydis is a registered trademark of R.P. Scherer Technologies, Inc., a
subsidiary of Catalent Pharma Solutions, Inc. Used with permission.
White Coat Productions
David Wasser, 202-256-4709
or
Pat Brogan, 703-462-0530
WhiteCoatProductions@gmail.com